We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nano-Magnets Produced by Bacteria Could Soon Target Tumors

By Biotechdaily staff writers
Posted on 27 Mar 2008
A new study by scientists in the United Kingdom and France has shown it is possible to customize the magnetic properties of tiny "nano” magnets produced by bacteria, and this technology could one day be developed to target cancer tumors.

The study is the work of Dr. More...
Sarah Staniland, from the School of Biological Sciences, University of Edinburgh (Scotland, UK), and colleagues, including Dr. Andrew Harrison, who is based at the Institut Laue-Langevin (Grenoble, France). The study was published in the early online issue in March 2, 2008 in the journal Nature Nanotechnology.

Some bacteria have the ability to digest iron into tiny nanoparticles of magnetite (Fe3O4) that are enclosed in lipid vesicles or membranes. These "magnetosomes,” as they are called, have considerable potential for medical use because of their greater biocompatibility and convenient narrow and uniform shape, compared to manmade versions. Bacteria use them like tiny compasses to help them search for environments rich in oxygen.

For use in medicine, a significant advantage could be gained if the magnetic properties of magnetosomes could be controlled, for instance, by chemically doping them; but before this study, that had not been demonstrated very successfully. Dr. Staniland and colleagues showed that they could inject the magnetosomes with three types of Magnetospirillum bacteria combined with cobalt.

The presence of cobalt in the magnetosomes increases their ability to stay magnetized when they are removed from a magnetic field. Measuring the coercive field necessary to reverse their magnetization showed that the increase in magnetic field strength conferred by the cobalt was between 36-45%, depending on the type of bacteria and the amount of cobalt absorbed.

Using a range of measuring techniques such as elemental analysis, X-ray absorption, and magnetic circular dichroism (effect of magnetic field on polarized light), Dr. Staniland and colleagues estimated the cobalt content of the magnetosomes to be between 0.2 and 1.4%.

The investigators concluded that their findings "provide an important advance in designing biologically synthesized nanoparticles with useful highly tuned magnetic properties.” The researchers speculated that magnetosomes that can stay magnetized longer could one day be used to target and destroy cancer cells. They could be guided to the tumor using magnetic force, and once there, by reversing the magnetic field they could be heated up and kill the cells. Another application could be to use them to transport drugs to the precise site of the tumor. Dr. Staniland reported that "for nanoparticles to be used in medicine you need them to be a very uniform size and shape and bacteria are very good for that.”

Explaining in a recent BBC News report, Dr. Staniland stated "you would move them with a normal magnetic field and then heat them with the opposing field.” Cancer experts reported nanotechnology like this is an exciting new field that could lead to new medical treatments, but the research is still very much at an early stage.


Related Links:
University of Edinburgh
Institut Laue-Langevin

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.